Valuation: Lupin Limited

Market Cap 1,106B 11.59B 10.06B 9.35B 8.62B 16.23B 16.53B 111B 43.32B 549B 43.51B 42.56B 1,847B P/E 2027 *
24.1x
P/E 2028 * 23.8x
Enterprise Value 1,060B 11.11B 9.65B 8.96B 8.26B 15.56B 15.84B 106B 41.52B 527B 41.7B 40.79B 1,771B EV / Sales 2027 *
3.55x
EV / Sales 2028 * 3.28x
Free-Float
52.97%
Yield 2027 *
0.53%
Yield 2028 * 0.52%
Manager TitleAgeSince
Chief Executive Officer 58 01/09/2013
Director of Finance/CFO 61 13/08/2007
Compliance Officer - 01/09/2024
Director TitleAgeSince
Director/Board Member 52 08/10/2008
Director/Board Member 58 01/01/1997
Chairman 82 11/08/2017
Change 5-day change 1-year change 3-year change Capi.($)
-4.55%-2.61%+51.95%+151.91% 1,030B
-3.66%-1.33%+52.95%+46.62% 617B
-2.24%+0.19%+35.97%+70.64% 455B
+0.83%+0.37%+38.62%+31.71% 350B
+0.51%+0.28%+35.11%+39.74% 299B
+0.02%+0.38%+12.31%+13.70% 265B
-7.64%-5.68%-3.85%-44.63% 225B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 163B
Average -1.08%+4.83%+29.57%+49.39% 401.41B
Weighted average by Cap. -0.59%+4.87%+37.99%+71.63%

Financials

2027 *2028 *
Net sales 298B 3.12B 2.71B 2.52B 2.32B 4.38B 4.46B 29.83B 11.68B 148B 11.73B 11.48B 498B 313B 3.27B 2.84B 2.64B 2.44B 4.59B 4.67B 31.26B 12.24B 155B 12.29B 12.03B 522B
Net income 45.84B 480M 417M 387M 357M 673M 685M 4.59B 1.8B 22.77B 1.8B 1.76B 76.57B 46.32B 485M 421M 391M 361M 680M 692M 4.63B 1.81B 23B 1.82B 1.78B 77.36B
Net Debt -45.91B -481M -418M -388M -358M -674M -686M -4.59B -1.8B -22.8B -1.81B -1.77B -76.68B -81.57B -854M -742M -689M -636M -1.2B -1.22B -8.16B -3.19B -40.51B -3.21B -3.14B -136B
Logo Lupin Limited
Lupin Limited is a leading Indian pharmaceutical group. Its products are used to treat tuberculosis, diabetes, asthma, cardiovascular diseases, infections, etc. The group's activity is organized around 2 areas: - design and production of generic and brand-name formulations; - production of active pharmaceutical ingredients. At the end of March 2022, the group had 15 production sites India (12), the United States, Mexico and Brazil. Net sales break down geographically as follows: India (39.4%), the United States (34.1%) and other (26.5%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-